aryl hydrocarbon receptor inhibitor IK-175

{
  "id": "MLC-T-ONC-011243",
  "term": "aryl hydrocarbon receptor inhibitor IK-175",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable selective inhibitor of the aryl hydrocarbon receptor (AhR; class E basic helix-loop-helix protein 76; bHLHe76), with potential immunomodulating and antineoplastic activities. Upon oral administration, AhR inhibitor IK-175 specifically targets and binds to AhR, inhibits AhR activation, prevents AhR-mediated signaling, and AhR-dependent tumor cell proliferation. Abrogation of AhR activation prevents the activation of immune-tolerant dendritic cells (DCs), regulatory T cells (Tregs) and decreases suppressive cytokines in the tumor microenvironment (TME). It stimulates cytotoxic T-cell activation and expansion. This may restore the immune response against tumor cells. AhR, a member of the basic helix-loop-helix/Per-Arnt-Sim (bHLH/PAS) family of transcription factors, plays key roles in regulating immunity and cellular differentiation. It mediates the expression of multiple immune related and tumor cell signal transduction and proliferation genes.",
  "synonyms": [
    "AhR antagonist IK-175",
    "AhR inhibitor IK-175",
    "AhRi IK-175",
    "AhRi KYN-175",
    "aryl hydrocarbon receptor antagonist IK-175",
    "aryl hydrocarbon receptor antagonist KYN-175"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/aryl-hydrocarbon-receptor-inhibitor-ik-175/"
}